EPHX2 and hypertensive disorder: The central role of sEH in the initiation and establishment of hypertension has been confirmed by evidence showing that treatment with sEH-selective inhibitors in Ang II-infused hypertensive rats increases the level of EETs, with attendant decrease in systolic blood pressure [14].